ArticleJournal of experimental & clinical cancer research : CR2022

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.

Cristina Chiriaco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.